久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Health collaborations forged at CIIE begin to bear fruit

By ZHOU WENTING in Shanghai | China Daily | Updated: 2021-01-19 10:10
Share
Share - WeChat
The stall of Novo Nordisk at the third China International Import Expo in Shanghai. [Photo/Xinhua]

Medical procedures, drugs, online programs serve patients, public across country

Two months after the third China International Import Expo ended in Shanghai, some exhibitors from the healthcare sector have disclosed that collaborations forged during the event have now materialized in the form of new drugs, innovative systems and technologies benefiting patients and the general public.

It transpires that several agreements were clinched between pharmaceutical multinationals and local healthcare authorities, institutions, schools and enterprises during the third CIIE.

Their partnerships' objective is to exploit inherent advantages and synergies in order to make the healthcare ecosystem in the country more innovative.

Executives of US-headquartered Boston Scientific said they had forged a strategic collaboration with Vivolight, a medical imaging device and technology provider based in Shenzhen, Guangdong province, during the third CIIE.

Their partnership may help drive improved clinical outcomes and technological progress in percutaneous coronary intervention, or PCI, procedures at hospitals.

This is said to be the first-ever strategic cooperation between a foreign enterprise and a local counterpart in the field of coronary intervention imaging.

The collaboration combines Boston Scientific's advantage in intravascular ultrasound and Vivolight's competitiveness in optical coherence tomography to provide patients with more accurate medical solutions for better treatment.

Experts said PCI procedures guided by imaging techniques such as IVUS and vascular OCT can significantly reduce the incidence of serious adverse events by making up for the lack of coronary angiography.

Industry experts said IVUS applied in intervention has been regarded as the "gold standard" in accordance with guidance from Europe and the United States.

However, in China, only 8 percent of PCI procedures are guided by imaging techniques, which compares with 15 percent in the US and more than 90 percent in Japan.

"For Boston Scientific, an important impetus of continuous growth in the China market is to collaborate with local partners to satisfy more local patients' unmet needs through diversified innovative channels," the company said in a written reply.

1 2 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 一级片免费观看 | 中国一级特黄真人毛片 | 色综合精品 | 欧美一级毛片久久精品 | 九九九免费视频 | 成人高清视频免费观看 | 国产精品路边足疗店按摩 | 国产精品亚洲片在线观看不卡 | 国产三级免费观看 | 亚洲成人偷拍 | 免费一级成人免费观看 | 国产高清视频在线 | 在线观看国产精品入口 | 国产成人精品午夜免费 | 国产手机视频 | 国产v片在线播放免费观 | 国产91精品一区 | 天堂中文字幕 | 日本在线www | 欧美日韩亚洲成色二本道三区 | 99国产精品热久久久久久夜夜嗨 | 特级一级毛片视频免费观看 | 毛片直接看| 99精品国产成人一区二区在线 | 日本一区二区三区精品视频 | 三级网站视频在线观看 | 久久久综合视频 | 性欧美一级 | 国产精品19禁在线观看2021 | 亚洲视频在线网站 | a级网站在线观看 | 国内主播福利视频在线观看 | 久久99精品这里精品3 | 狠狠色婷婷丁香综合久久韩国 | 欧美a级完整在线观看 | 日本亚洲成高清一区二区三区 | 亚洲欧美日韩综合一区久久 | 日韩久草 | 国产一区二区久久 | 久久精品久久精品久久精品 | 国产男女猛烈无遮档免费视频网站 |